Ken Griffin Nephros Inc Call Options Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NEPH
# of Institutions
18Shares Held
4.28MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.6MShares$5.29 Million1.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA202KShares$296,9310.0% of portfolio
-
Bard Associates Inc Chicago, IL172KShares$253,3850.11% of portfolio
-
Geode Capital Management, LLC Boston, MA85.2KShares$125,3160.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL57.2KShares$84,0980.0% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $15.2M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...